Industry News
INVESTMENTS
► KKR acquired a majority stake in India-based healthcare chain Meitra Hospital. #Asia
► Actis agreed to acquire a 90% stake in 800 Super, a Singapore-based integrated environmental management company. #Asia
► IFC, EBRD and Turkven invested in Çağatay, a Turkey-based dry pet food producer. #CEE
► Dragonball Capital led a CNY1b (~USD140.2m) investment in Beatbot, a China-based developer of robotic pool cleaners, with participation from Hillhouse Capital, Shunwei Capital, Cathay Capital and others. #Asia
► JiveMauá agreed to invest BRL460m (~USD86m) in Azevedo e Travassos, a Brazil-based construction and civil engineering company. #LatinAmerica
► Qiming Venture Partners led a USD63m Series B2 for AusperBio, a clinical-stage biopharmaceutical company operating across the US and China, with participation from HanKang Capital, CDH Investments, YuanBio Venture Capital and others. #Asia
► Victory Park Capital provided a USD50m credit facility for ADDI, a Colombia-based point-of-sale lending platform. #LatinAmerica
► Founders Fund and Sequoia Capital led a USD35m Series A for Enter, a Brazil-based AI startup developing a legal defense platform for enterprises. #LatinAmerica
► Stride Ventures led a USD33m debt financing for erad, a Saudi Arabia-based Shariah-compliant financing platform for SMEs across the GCC. #MiddleEast
► Mirova provided ~USD10m in debt financing for Arc Ride, a Kenya-based e-mobility battery-as-a-service provider. #Africa
► Purple Ventures led a USD1.5m pre-Series A for Klide, a Singapore-based private credit investment platform. #Asia
► Credicorp Capital invested COP45b (~USD11.5m) in Zona Franca Gachancipá, a Colombia-based industrial park. #LatinAmerica
FUNDRAISING
► EcoEnterprises Fund reached a USD100m first close for its fourth impact fund focused on climate and biodiversity investments in Latin America. #LatinAmerica
EXITS
► Advent exited a 8.92% stake in India-based CDMO platform Cohance Lifesciences via a bulk deal for INR30.94b (~USD351m). Advent will hold a 24.16% stake in the company following the transaction. #Asia
► GenFleet Therapeutics, a China-based clinical-stage biotechnology company, raised HKD1.8b (~USD233.9m) through an IPO on the Hong Kong Stock Exchange. #Asia